Evidence map›Paper›PMID 30283737›Full record

ArticleEuropean thyroid journal2018

How Do We Improve the Impact of Iodine Deficiency Disorders Prevention in Europe and Beyond?

Henry Völzke, Iris Erlund, Alicja Hubalewska-Dydejczyk, Till Ittermann, Robin P Peeters, Margaret Rayman, Monika Buchberger, Uwe Siebert, Betina H Thuesen, Michael B Zimmermann and 2 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European thyroid journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 4 countries.

Henry VölzkeInstitute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
Iris ErlundDepartment of Public Health Solutions, National Institute for Health and Welfare (THL), Helsinki, Finland.
Alicja Hubalewska-DydejczykDepartment of Endocrinology, Jagiellonian University Medical College, Krakow, Poland.
Till IttermannInstitute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
Robin P PeetersDepartment of Internal Medicine, Rotterdam Thyroid Centre, Erasmus Medical Centre, Rotterdam, the Netherlands.
Margaret RaymanUniversity of Surrey, Surrey, United Kingdom.
Monika BuchbergerDepartment of Public Health and Health Technology Assessment, UMIT, University for Health Science, Medical Informatics and Technology, Hall, Austria.
Uwe SiebertDepartment of Public Health and Health Technology Assessment, UMIT, University for Health Science, Medical Informatics and Technology, Hall, Austria.
Betina H ThuesenResearch Centre for Prevention and Health, Glostrup, Denmark.
Michael B ZimmermannSwiss Federal Institute of Technology, Zürich Department of Health Sciences and Technology, Zürich, Switzerland.
Stefan GrünertBiolution GmbH, Vienna, Austria.
John H LazarusInstitute of Molecular Medicine, Cardiff University, Cardiff, United Kingdom.
Universitätsmedizin Greifswald · DEFinnish Institute for Health and Welfare · FIJagiellonian University · PLUniversity of Surrey · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIodine deficiency disorders (IDD) represent a global health threat to individuals and societies. IDD prevention programmes have been introduced in many parts of the world. However, challenges remain, particularly in Europe due to fragmentation and diversity of approaches that are not harmonized.

objectivesThis review is dedicated to the public-health impact of IDD prevention programmes. It sums up experiences collected by the EUthyroid consortium so far and provides information on stakeholders that should be involved in actions directed to improve the impact of IDD prevention.

methodsA joint European database for combining registry-based outcome and monitoring data as well as tools for harmonizing study methods were established. Methods for analyzing thyroglobulin from a dried blood spot are available for assessing the iodine status in the general population and at-risk groups. Mother-child cohorts are used for in-depth analysis of the potential impact of mild-to-moderate iodine deficiency on the neurocognitive development of the offspring. A decision-analytic model has been developed to evaluate the long-term effectiveness and cost effectiveness of IDD prevention programmes.

resultsEUthyroid has produced tools and infrastructure to improve the quality of IDD monitoring and follows a dissemination strategy targeting policymakers and the general public. There are tight connections to major stakeholders in the field of IDD monitoring and prevention.

conclusionsEUthyroid has taken steps towards achieving a euthyroid Europe. Our challenge is to inspire a greater sense of urgency in both policymakers and the wider public to address this remediable deficit caused by IDD.

Indexed as

EpidemiologyIodineOutcomes researchPrevention

Identifiers

PMID30283737
PMCPMC6140605
OpenAlexW2887117747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.